This persistent hypoxic condition induces changes in HGSOC gene expression that promote cancer progression, invasion as well as resistance to chemotherapy and the “angiogenic switch”, through transcriptional activation of the pro-angiogenic vascular endothelial growth factor (VEGF) gene [4,5]. This evidence concerns the gene VEGFA and cancer.